Healthier Markets. Healthier Lives.

Innovative finance for affordable and accessible healthcare

We are a social finance company with a difference. We are motivated by purpose, not profit.

Using innovative finance tools, we secure lower prices and sustainable supply of medical products for people in low- and middle-income countries. Our work combines commercial insight and rigour with a relentless pursuit of health impact.

MedAccess is an independent company, wholly owned by the UK’s CDC Group plc.

OUR IMPACT

Read our 2020 Annual Report

COVID-19 brought the extent and consequences of unequal access to healthcare into sharp focus. Find out how our partnerships are increasing access to life-saving healthcare products.

Find out more

Two scientists using a Hologic Panther machine

ABOUT US

Who we are

We believe in a world where everyone can access the medicines and healthcare products they need to lead healthy lives.

Learn more

OUR WORK

Innovative finance for development

Our innovative finance tools enable manufacturers and procurers to enter into partnerships that increase access to medical products for people who need them.

Learn more

Latest News & Insight

News – 13 Sep '21

MedAccess welcomes Vicky Johnson as new Chief Financial Officer

Vicky will lead on all aspects of financial management, control and reporting and she joins MedAccess' Senior Management Team.

News – 16 Aug '21

Improving availability of patient-friendly tuberculosis preventive therapy

MedAccess' volume guarantee will help increase availability of an innovative treatment for latent tuberculosis.

News – 04 Aug '21

New financing agreement boost for malaria vaccine

Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine ahead of key policy and funding decisions.

Insight – 07 Jul '21

Getting new malaria control technologies to communities

New malaria technologies are tackling the problem of insecticide resistance in mosquitos. Dr. Tom McLean from IVCC discusses how to get these new tools to the people who need them.